With a share price of $1,182, Eli Lilly (LLY) is positioned for about 76% potential growth over the next three years in a ...

In the latest close session, Eli Lilly (LLY) was down 2.48% at $1,152.54. The stock fell short of the S&P 500, which registered a gain of 0.38% for the day. Elsewhere, the Dow gained 0.02%, while the ...

The Number $8.662 billion. That is what Mounjaro alone generated for Eli Lilly (NYSE:LLY | LLY Price Prediction) in the first ...

Eli Lilly (LLY) shares are inching higher on Thursday morning after the pharmaceutical behemoth announced a definitive ...

At $1,189, Eli Lilly (LLY) looks set up for roughly 76% of upside over the next three years under a conservative scenario.

Eli Lilly has made some massive breakthroughs in pharmaceutical technology, but will it translate to money for investors? Read our forecast and find out.

Eli Lilly has whipsawed shareholders in 2026, but one under-the-radar catalyst in its pipeline could change the trajectory ...

The market leader in obesity shots, Lilly hasn’t made a major dent in the pill market yet.

Eli Lilly and Company’s (LLY) new drug line-up is expected to generate higher revenues and earnings. Also, LLY’s robust earnings, favorable analyst estimates, and higher-than-industry profitability ...

Eli Lilly and Company (NYSE:LLY) is one of the safe stocks for beginners to buy in 2026. Eli Lilly and Company (NYSE:LLY) received a rating update from Leerink on June 25. The firm lifted the price ...

Eli Lilly (LLY) stock and Novo Nordisk (NVO) stock are in focus as Medicare offers coverage for GLP-1 weight-loss drugs for only $50 per month. Read more here.